Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Banks On ICDs To Spark Stock Growth; Index Slips In 2005

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific is counting on Guidant shareholders preferring its takeover offer to J&J's to regain Wall Street enthusiasm in the face of diminishing competitive advantages for Taxus and a 31% stock decline in 2005
Advertisement

Related Content

NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill
Ortho Firms And Docs Claim That Gainsharing Reality Is Not Meeting Its Hype
KCI Looks To New VAC Applications In The Face Of Reimbursement Woes
St. Jude Offers $1.3 Bil. For ANS, Citing Low-Voltage Technology Synergy
Boston Scientific Inks Pact With Aspect For Depression, Alzheimer’s Tests
Carotid Stent, AAA Market Entry: Boston Scientific Moves On Earn-Outs
Boston Scientific, J&J Dwell In Separate REALITY; Data Swamps ACC
Boston Scientific, J&J Dwell In Separate REALITY; Data Swamps ACC
Boston Scientific’s Pulse Races At Thought Of CRM Prospects
Advertisement
UsernamePublicRestriction

Register

MT023073

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel